Neuron Bio S.A. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2012
2013
2014
2015
2016
Cash & Short Term Investments
960.20
274.20
375.80
249.80
1,904.80
Total Accounts Receivable
1,036.80
602.10
831.70
710.10
1,121.30
Other Current Assets
27.70
3.30
24.60
-
14.60
Total Current Assets
2,024.70
879.60
1,232.20
959.90
3,040.70
Net Property, Plant & Equipment
9,815.10
12,536.20
12,457.50
12,697.20
12,434.90
Total Investments and Advances
2,414.90
2,513.40
6,513.50
4,498.70
614.40
Long-Term Note Receivable
153.60
128.80
33.30
27.80
22.30
Intangible Assets
4,556.50
4,406.20
3,606.70
3,310.60
6,350.90
Total Assets
23,923.10
26,381.40
30,190.50
27,850.20
33,520.00
ST Debt & Current Portion LT Debt
4,220.20
4,409.40
2,496.80
3,596.80
805.50
Accounts Payable
583.30
777.70
169.00
99.10
5,676.00
Income Tax Payable
78.60
209.50
54.90
39.30
109.90
Other Current Liabilities
575.60
1,216.50
2,175.00
2,698.50
4,960.10
Total Current Liabilities
5,457.70
6,613.10
4,895.60
6,433.70
11,551.50
Long-Term Debt
7,223.70
9,458.80
9,607.90
8,470.10
2,276.80
Deferred Taxes
4,148.30
4,875.30
5,443.20
5,666.00
10,308.60
Other Liabilities
-
-
-
-
7,511.20
Total Liabilities
13,491.40
17,113.80
15,407.60
15,593.70
22,087.60
Common Equity (Total)
7,683.90
6,718.90
6,975.90
5,363.60
7,430.60
Total Shareholders' Equity
7,683.90
6,718.90
6,975.90
5,363.60
7,430.60
Total Equity
7,683.90
6,718.90
6,975.90
5,363.60
9,028.20
Liabilities & Shareholders' Equity
23,923.10
26,381.40
30,190.50
27,850.20
33,520.00
Accumulated Minority Interest
-
-
-
-
1,597.50
Non-Equity Reserves
2,747.80
2,548.70
7,807.00
6,892.90
2,404.30

About Neuron Bio

View Profile
Address
P. T. S. Granada
Granada Andalusia 18016
Spain
Employees -
Website http://www.neuronbio.com
Updated 07/08/2019
Neuron Bio SA is a a biotechnological company. It operates through the following sectors: Neuron Biolabs, and Neol Bio. The Neuron Biolabs sector develops biosolutions for application in the pharmaceutical and agri-food industries through its specialised divisions.